Trailblazer Interviews
-
Understanding The Amazing Benefits Of Organoids With Samsung's Dr. Alexis Santana
1/15/2026
Organoids are one of the tools the FDA identified as a way to reduce animal testing in pre-clinical studies, but they do much more. Dr. Alexis Santana discusses Samsung Biologics' organoid services: what they are and how they are used, their ability to grealty reduce time from discovery through commercialization, and how they will shape the future of drug devlopment.
-
Jeremy Victor On Becoming More
12/30/2025
An interview with Jeremy Victor, CEO of MoreScore XPERIENCE, author of The MORE Effect, and the host of the Speed of AI Podcast. We discuss his new book, the impact of AI on business and people, his origin story, and how to become MORE by helping others get what they want in life.
-
Being Your Client's Valuable Travel Companion In Their Drug Development Journey
12/12/2025
Northern Spain is one of the fastest growing regions of the biopharmaceutical industry in the EU. Elena Erroba, Chief Commercial Officer, tells us why and how 3PBiovian is making an impact as biologic technology scouts and helping innovators navigate the complex journey of turning a drug innovation into a commercial reality.
-
Creating A Better Solution For Pharmaceutical Contract Manufacturing
12/5/2025
An interview with Rick Hancock, CEO & Hannah Kinney, Director of Business Development, Argonaut Manufacturing Services. We discuss the why behind Argonaut, their custmer-centered approach , and why partnerships are a key part of their solution.
-
Global Economic Uncertainty & How to Thrive with Antifragile Business Operations
11/17/2025
Joe Renny, Head of Corporate Development at CatSci Ltd., believes that global economic uncertainty is the new normal that is hear to stay, and to succeed we must embrace an operational framework to not only survive, but thrive. And that framework is antifragillity!
-
Overcoming Chronic Inefficiencies in Drug Development with AI
10/24/2025
An interview with Ryan Hawkins, Founder of TransferAI, on how AI is addressing the chronic inefficiencies in the drug development process and delivering therapies more quickly to patients.
-
Develop Effective Marketing Plans for 2026 and Beyond
10/21/2025
An interview with Christine Slocumb, B2B marketing expert, author of Stop Starvation Marketing and Exit Advisor at the Whisper Group for healthcare, biotech and technology companies. Chris shares her thoughts on current market conditions in life sciences, what business leaders can expect in 2026, and how to develop marketing plans to thrive in 2026 and beyond.
-
How Great Storytelling Drives Better Audience Engagement
10/1/2025
Paul Furiga joins me for this edition of the Trailblazers to speak about how great storytelling can be a key part of your B2B marketing strategy. He shares valuable insights from his career as a journalist, public relations professional and gifted storyteller. Since recording our interview, Paul’s company, WordWrite, has become part of Vendilli Digital Group.
-
Launching A New Customer-Centered Offering - How To Do It Right
9/22/2025
Andy Holt, Chief Commercial Officer at Viralgen Vector Core, speaks about introducing a new CDMO service based on an unmet need among gene therapy drug innovators. He describes the process of market analysis, target audience analysis, defining and refining the service capabilities, gaining the support of key stake holders in his organization, and developing and executing their internal and external messaging.
-
B2B Content Marketing & Measuring Results
9/12/2025
This episode of the Trailblazers is so packed full of common sense, actionable advice regarding B2B marketing, it is impossible to succinctly summarize it. But here I’ll give it a try! What should you stop doing and do more of, what is good content marketing, what is good content, you must start paying much more attention to what your target audience wants & also what they need to solve the problems they have, how to really measure results, make sure you have a clear why to your marketing strategy and what you want to measure, how to really measure attribution…and much, much more!